Company profilePharmaceutical#711 of 1,318 in Pakistan✓ No DRAP alerts

VENTURE CHEMICAL & PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 13 brands · 19 molecules

Ranked #5 of 10 companies in Other Antianemic Preparations (Erythropoietin Products)

13 registered products 12 pharmaceutical brands 19 distinct molecules 0 DRAP alerts

Company overview

13
registered products
12
pharmaceutical brands
19
distinct molecules
2
therapeutic classes
0
DRAP alerts

VENTURE CHEMICAL & PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 13 product registrations across 19 distinct molecules. Its portfolio is concentrated in Other Antianemic Preparations (Erythropoietin Products) and Blood Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by VENTURE

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20251

Top molecules by brand count

Therapeutic classes

Other Antianemic Preparations (Erythropoietin Products) · 1Blood Conditions · 1

Conditions treated

Haematopoiesis · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official2 products · Rs 495.67 – Rs 826.12
DVAGO2 products · Rs 2,040 – Rs 2,580
Servaid2 products · Rs 1,380 – Rs 1,725
Median across source: Rs 1,552.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

CCL Pharmaceuticals (Pvt.) Ltd. holds 159 molecules not in this portfolio
3) 40Mg)Alpha KetoanaloguesAmino AcidsAmiodaroneAmlodipineApixaban
POLYFINE CHEMPHARMA (PVT) LTD. holds 3 molecules not in this portfolio
GlimepirideMetoclopramideMetoclopramide Hci
SHROOQ PHARMACEUTICALS holds 22 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCefiximeCiprofloxacinDiclofenac

Get the full profile for VENTURE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.